Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Diabetes news

Show

From To
High cholesterol and diabetes common among people on HIV treatment in Malawi

High LDL cholesterol levels and diabetes are much more common in people living with HIV on long-term antiretroviral treatment in Malawi compared to people of

Published
04 January 2018
By
Keith Alcorn
Diabetes in people with HIV over 50 overwhelmingly linked to old antiretrovirals, not age or body weight

People with HIV over the age of 50 are more likely to have developed type 2 diabetes if they started antiretroviral treatment before 1999 or

Published
03 January 2018
By
Keith Alcorn
People with HIV less likely to be prescribed key drugs to reduce cardiovascular risk

Physicians in the United States are less likely to prescribe key recommended medications for the prevention of cardiovascular disease to people with HIV compared to

Published
12 December 2017
By
Michael Carter
Older antiretroviral regimens raise diabetes risk in HIV-positive adults

HIV-positive adults who initiated older formulations of antiretroviral therapy are more likely to develop type 2 diabetes than patients who initiated therapy between 2010 and 2015, according to study findings reported in BMJ Open Diabetes Research.

Published
05 December 2017
From
Healio
Drinking three or more cups of coffee a day halves the risk of dying for people with HIV/HCV co-infection

Drinking three or more cups of coffee a day halves the risk of death from any cause for people with HIV/hepatitis C virus (HCV) co-infection,

Published
03 October 2017
By
Michael Carter
Many adults with diabetes delay insulin therapy

Three in ten adults with type 2 diabetes who need to start taking insulin to lower their blood sugar don’t begin treatment when their doctors tell them to, a recent study suggests.

Published
02 October 2017
From
Reuters
Widely used diabetes test may not be suitable for Africans

People of African descent may mistakenly get the all-clear from a widely used type 2 diabetes test called HbA1c, according to an international study. The findings have important implications as they suggest that using this test as the sole means to diagnose diabetes would do harm, said University of the Witwatersrand endocrinologist Alisha Wade.

Published
14 September 2017
From
Medical Brief
People with HIV are at risk for liver fibrosis and steatosis

Metabolic syndrome, type 2 diabetes and obesity are risk factors for the development of liver fibrosis and steatosis (liver fat accumulation) in people living with

Published
21 August 2017
By
Liz Highleyman
Many people living with HIV at high risk of cardiovascular disease are not on statins

Only half of HIV-positive patients at a Chicago clinic eligible for statin therapy according to the latest US guidelines are receiving this treatment, investigators report in the

Published
19 July 2017
By
Michael Carter
Curing hepatitis C improves diabetes control

Curing hepatitis C infection with direct-acting antiviral treatment improves diabetes control in people with more severe type 2 diabetes, a review of patients treated in

Published
06 July 2017
By
Keith Alcorn
← First12345...8Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.